January 1, 1986Journal of Antimicrobial Chemotherapy

In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with β-lactamase inhibitors

View Full Paper

Ask AI

Bookmark

Abstract

A. L. BARRY, R. N. JONES, R. R. PACKER; In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combi

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Barry et al. (1986) studied this question.

synapsesocial.com/papers/6a94d924e5087c6def7c3bb8 https://doi.org/10.1093/jac/17.1.125

View Full Paper

Ask AI

Bookmark

Abstract

A. L. BARRY, R. N. JONES, R. R. PACKER; In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combi